Identification and characterization of survival-dependent genes in esophageal cancer via the DepMap database: unraveling their association with immune infiltration
Authors:
Open Access
- 22 June 2025
- journal article
- research article
- Published by Springer Nature in Discover Oncology
- Vol. 16 (1) , 1-22
Abstract
Background: Esophageal cancer ranks as the 11th most diagnosed cancer worldwide and the 7th leading cause of cancer-related deaths, mainly due to late-stage diagnosis. Identifying novel biomarkers is essential for enhancing prognostic evaluations and targeting patients for immunotherapy. Methods: We used the DepMap database to identify survival-dependent genes in esophageal carcinoma cells. A prognostic model was developed using univariate and multivariate Cox regression and LASSO, validated with the GEO dataset. WGCNA and GSEA analyses were conducted to explore mechanisms, alongside ESTIMATE and ssGSEA for prognosis. Results: We constructed a novel four-gene prognostic signature (CPSF6, IGBP1, MTG2, TCP1) based on SDG expression and survival data. This signature stratified esophageal cancer patients into high- and low-risk groups with significantly different survival, with the high-risk group showing shorter survival. WGCNA and GSEA analyses linked prognosis to immune pathways, including interferon-γ response and IL6-JAK-STAT3 signaling. ssGSEA revealed reduced infiltration of 19 immune cell types in high-risk patients, and ESTIMATE analysis confirmed the association between immune infiltration and poor prognosis. Conclusion: This study establishes a four-gene survival signature for esophageal cancer that distinguishes high-risk from low-risk populations, providing novel prognostic indicators. Immune response pathways were downregulated in high-risk patients, offering potential targets for understanding esophageal cancer mechanisms and developing immunotherapeutic strategies.Keywords
Funding Information
- Ecology and Environment Department of Hunan (HBKYXM-2023021)
This publication has 41 references indexed in Scilit:
- A novel pipeline for prioritizing cancer type‐specific therapeutic vulnerabilities using DepMap identifies PAK2 as a target in head and neck squamous cell carcinomasMolecular Oncology, 2023
- Precise patient stratification in esophageal cancer: Biomarkers for immunochemotherapyCancer Cell, 2023
- CCT6A promotes esophageal squamous cell carcinoma cell proliferation, invasion and epithelial-mesenchymal transition by activating TGF-β/Smad/c-Myc pathwayIrish Journal of Medical Science (1971 -), 2023
- CPSF6-mediated XBP1 3’UTR shortening attenuates cisplatin-induced ER stress and elevates chemo-resistance in lung adenocarcinomaDrug Resistance Updates, 2023
- Esophageal cancer in China: Practice and research in the new eraInternational Journal of Cancer, 2022
- The development and progress of nanomedicine for esophageal cancer diagnosis and treatmentSeminars in Cancer Biology, 2022
- Immunotherapy for Advanced Esophageal Squamous Cell Carcinoma—Renewed Enthusiasm and a Lingering ChallengeJAMA Oncology, 2021
- Esophageal cancer: Risk factors, genetic association, and treatmentAsian Journal of Surgery, 2018
- Defining a Cancer Dependency MapCell, 2017
- The Male Predominance in Esophageal AdenocarcinomaClinical Gastroenterology and Hepatology, 2016